BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Sandoz announces changes in the Board of Directors

  The Board of Directors of Sandoz announced that it proposes Graeme Pitkethly for election to its Board of Directors at the company’s next Annual General Meeting on April 30, 2024.

  February 1, 2024

   · 

  4 min read
• Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference

  Kuros Biosciences, a leader in next generation bone graft technologies, announced it will present at the CG 2024 Musculoskeletal Conference, to be held in San Francisco on February 12, 2024.

  February 1, 2024

   · 

  3 min read
• Press Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline

  Strong pipeline including record 12 blockbuster opportunities under clinical evaluation detailed at recent R&D Day.

  February 1, 2024

   · 

  4 min read
• Business

  Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee

  François-Xavier Roger will be appointed Chief Financial Officer and a member of Sanofi’s Executive Committee effective April 1, 2024.

  February 1, 2024

   · 

  3 min read
• Drug Development

  Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation

  Sensorion announces the recruitment of the last patient in its Phase 2a clinical trial of SENS-401 for residual hearing preservation in adult patients following cochlear implantation.

  February 1, 2024

   · 

  5 min read
• Business

  Takeda Announces Chief Financial Officer Succession

  Takeda announced that Costa Saroukos, chief financial officer, has decided to leave Takeda to return to his home-country of Australia to be closer to family.

  February 1, 2024

   · 

  8 min read
• Business

  Legacy Novozymes delivers solid last full-year results

  In the 2023 financial year, legacy Novozymes delivers 5% organic sales growth – 6% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 25.4%, and ROIC including goodwill before special items* of 16.5%.

  February 1, 2024

   · 

  2 min read
• Business

  Michael Austwick Joins Verona Pharma as Non-Executive Director

  Verona Pharma plc announces Mr. Michael Austwick has joined the board as a Non-Executive Director.

  February 1, 2024

   · 

  4 min read
• Business

  Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024

  Genflow Biosciences Plc is pleased to provide a year-end review and summary of its progress during 2023 and defined strategic priorities for 2024.

  February 1, 2024

   · 

  6 min read
• Business

  HUTCHMED to Announce 2023 Final Results

  HUTCHMED Limited will be announcing its final results for the year ended December 31, 2023 on Wednesday, February 28, 2024 at 6:30 am Eastern Standard Time / 11:30 am Greenwich Mean Time / 7:30 pm Hong Kong Time.

  February 1, 2024

   · 

  1 min read